Treatment of Early Parkinson's Disease: Are Complicated Strategies Justified?
- 31 July 1996
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 71 (7) , 659-670
- https://doi.org/10.1016/s0025-6196(11)63004-8
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomaticAnnals of Neurology, 1992
- Clinical Neuromythology IX — Pyramid sale in the bucket shopNeurology, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]DeprenylJournal of Neurochemistry, 1987
- MPTPNeurology, 1986
- Oxygen radicals and the nervous systemTrends in Neurosciences, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979